Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- OKTA -10.2%, PLAB -4.8%, API -4.7%, SMTC -2.8%, CPRI -2.1%
Other news:
- IFRX -50.6% (reports IDMC recommends interim analysis for Vilobelimab Phase 3 Trial be stopped due futility)
- CODI -12.9% (takes action to improve its financial position)
- GLXY -8.5% (files for 29 mln share offering, comprised of 24.15 mln shares offered by the company and 4.85 mln shares by selling shareholders, including its founder)
- SOC -7.8% (satisfied final operational condition to restart of the Onshore Pipeline)
- GDS -6.7% (prices offering of ADSs and convertible notes)
- SKIN -4.7% (confirmed it issued $250 mln principal amount of 7.95% Convertible Senior Secured Notes due 2028 on May 27 with restrictions)
- EOLS -4.2% (CFO resigns)
- NFGC -3.8% (announces CAD 49 million bought deal financing and CAD 20 million private placement: continued support with lead orders by strategic investor Eric Sprott) VIK -2.6% (prices secondary offering of 30,531,917 ordinary shares at $44.20 per share)
- CNP -2% (prices offering of 21,621,622 shares of its common stock at $37.00 per share)
- STLA -1% (names Antonio Filosa as new CEO)